LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

New Aspects of Clinical and Immunological Characteristics in Patients with Anti-asparaginyl tRNA synthetase (anti-KS) Autoantibody.

Photo by nappystudio from unsplash

OBJECTIVES Anti-asparaginyl tRNA synthetase (anti-KS) antibody is present in patients with interstitial lung disease (ILD) accompanied by polymyositis/dermatomyositis (PM/DM). We examined clinical/immunological features of these patients. METHODS PM/DM or ILD… Click to show full abstract

OBJECTIVES Anti-asparaginyl tRNA synthetase (anti-KS) antibody is present in patients with interstitial lung disease (ILD) accompanied by polymyositis/dermatomyositis (PM/DM). We examined clinical/immunological features of these patients. METHODS PM/DM or ILD patients were screened for autoantibodies and clinical/immunological data were collected retrospectively. ILD was diagnosed by computed tomography and clinical/immunological features of anti-KS positive patients were compared with anti-Jo-1 positive patients. RESULTS Sixteen anti-KS positive patients (female=11; male=5; average age 63.6 years (range, 40-81)) were diagnosed: 7 had ILD, 4 had clinically amyopathic DM (CADM) and ILD, 3 had Sjögren's Syndrome (SS) and ILD, one each had rheumatoid arthritis and ILD, or CADM/SS overlap and ILD. All patients had ILD with chronic onset and clinical course; 11/16 (69%) had non-specific interstitial pneumonia, 5 (31%) had usual interstitial pneumonia pattern. Regarding skin manifestations, 4 (27%) had typical DM rash and 11 (69%) had mechanic's hands. All anti-KS positive patients had no clinical muscle weakness or serum creatine kinase elevation; 8/16 patients (50%) had sicca symptoms at a significantly high frequency compared with anti-Jo-1 positive patients (50% vs. 11%, P=0.01). CONCLUSIONS Anti-KS positive patients might form a distinguishable subset closely associated with sicca symptoms, CADM, and chronic-type ILD with a relatively favorable prognosis.

Keywords: trna synthetase; asparaginyl trna; clinical immunological; anti asparaginyl; anti positive; positive patients

Journal Title: Modern rheumatology
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.